For example, ladostigil is a dual cholinesterase–monoamine oxidase-B (MAO-B) inhibitor currently being researched for the treatment of Alzheimer's disease and other neurodegenerative diseases (van der Schyf, 2011). The gene discussed is MAOB; the disease is early-onset autosomal dominant Alzheimer disease.